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peak expiratory fl ow were observed after PMR. The heart 
rate showed a signifi cant increase in the coeffi cient of 
variation, root mean square of successive differences 
and high frequency ranges, in addition to a signifi cant 
reduction in low and middle frequency ranges. A sig-
nifi cant reduction on three of fi ve State-Trait Anger Ex-
pression Inventory scales, and a signifi cant increase on 
seven of eight SF-36 scales were observed.  Conclusions: 
PMR appears to be an effective method to improve blood 
pressure, lung parameters and heart rate, and to de-
crease anger levels, thus enhancing health-related qual-
ity of life in pregnant women with bronchial asthma. 
 Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 Asthma may be the most common potentially serious 
medical problem in pregnancy, and adequate treatment 
is important to prevent greater risks for both mother and 
child  [1] . In one third of pregnant women, asthma im-
proves during pregnancy, in one third it stays the same, 
while in the remainder it worsens  [2] . 
 As a chronic disease, bronchial asthma infl uences the 
patient’s daily life in most psychosocial domains  [2] . 
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 Abstract 
 Background: Asthma is a serious medical problem in 
pregnancy and is often associated with stress, anger and 
poor quality of life.  The aim of this study was to deter-
mine the effi cacy of progressive muscle relaxation (PMR) 
on change in blood pressure, lung parameters, heart 
rate, anger and health-related quality of life in pregnant 
women with bronchial asthma.  Methods: We treated a 
sample of 64 pregnant women with bronchial asthma 
from the local population in an 8-week randomized, pro-
spective, controlled trial. Thirty-two were selected for 
PMR, and 32 received a placebo intervention. The sys-
tolic blood pressure, forced expiratory volume in the fi rst 
second, peak expiratory fl ow and heart rate were tested, 
and the State-Trait Anger Expression Inventory and 
Health Survey (SF-36) were employed.  Results: Accord-
ing to the intend-to-treat principle, a signifi cant reduc-
tion in systolic blood pressure and a signifi cant increase 
in both forced expiratory volume in the fi rst second and 
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Pregnancy in asthmatic women is often associated with 
stress, anxiety and anger, which appears to be signifi cant-
ly related to their quality of life  [3–8] and to be associ-
ated with their impulsivity and possible mental health 
impairment  [9] . The health-related quality of life could 
be used together with asthma control measures to assess 
treatment effi cacy  [10] . Treatment for aggression could 
generally combine pharmacological with psychothera-
peutic measures  [11–14] . Nonpharmacological measures 
include inter alia behavioral techniques aimed at reduc-
ing impulsivity, as well as anger management techniques 
and relaxation  [11] . 
 In considering the use of any therapeutic agent in preg-
nant patients, safety aspects must be carefully weighed 
against potential benefi t  [15 , cf.  16] . However, inhaled 
asthma medications and theophylline should be used 
when indicated  [1] . Pregnant asthma patients are also a 
distinct group of patients with different treatment re-
quirements from other asthma patients  [15] . Noncompli-
ance with prescribed antiasthma medication due to anx-
iety regarding the health of the unborn child is considered 
to be a major problem  [15] . Now, it is also known that 
anxiety and emotional stress exacerbate or predispose to 
acute and chronic asthma  [17] . Subjects with bronchial 
asthma, including pregnant women, could also probably 
benefi t from relaxation techniques  [18–20] . One of the 
most simple and easily learned techniques for relaxation 
is progressive muscle relaxation (PMR), currently a wide-
ly-used procedure that was originally developed by Jacob-
son in 1939 and which, in the literature, resulted in the 
greatest effects on behavioral and self-report measures of 
relaxation  [11 , cf.  21, 22] . 
 The extent of relaxation experienced by asthma suffer-
ers can be depicted through the measurement of systolic 
blood pressure (SBP), lung parameters and heart rate 
variability [cf.  23–26] . 
 So far no reports have been published of studies in 
which the effects of PMR in pregnant women with asth-
ma were examined. The purpose of this study was to ex-
amine the effi cacy of PMR on changes in SBP, lung pa-
rameters, heart rate variability, anger level and health-
related quality of life in pregnant women with bronchial 
asthma. 
 Method 
 Participants 
 Pregnant women who suffered from bronchial asthma were re-
cruited through advertisements. A requirement was that they were 
regularly seen by a gynecologist. The criteria for exclusion were use 
of medication, anything other than the usual types of asthma med-
ication during the previous 4 weeks (common antiasthma agents, 
e.g. beta-2 agonists such as salbutamol, do not infl uence heart rate 
variability  [27] ), psychosis, severe anxiety and/or depression, sub-
stance abuse, the current use of psychotropic medication [cf.  28–
30] or psychotherapy as well as smoking and hypertension. 
 Subjects were next invited to participate in face-to-face inter-
views. The Structured Clinical Interview (SCID I and II) was then 
carried out for each subject in order to exclude mental disease. The 
subjects then underwent a physical and laboratory examination. 
 The necessary sample size was calculated for a type I error of 
5% (z 1  = 1.96) and a power analysis of 80% (z 2  = 0.842), based on 
the mean value (m 1  = 25.7 and m 2  = 22.0) and standard deviation 
(s 1  = 7.9 and s 2  = 7.0) for the root mean square of successive differ-
ences (RMSSD; see below), which were obtained from a small pilot 
study. The formula is n (per group) = [(z 1  + z 2 ) 2   ! (s 1  2  + s 2  2 )]/
(m 1  – m 2 ) 2   [31] . This resulted in a group size of 64 patients: 32 of 
them were chosen for the PMR group (PMR-G) and 32 for the con-
trol group (CG) using randomized numbers generated by an Excel 
table ( fi g. 1 ). The clinic administration conducted the randomiza-
tion procedure confi dentially. After the subjects had received a 
complete description of the study, written informed consent was 
obtained. 
 Assessment 
 The groups were compared by means of blood pressure and lung 
parameter measurement, and through ECG recording by measur-
ing the autonomous heart rate parameters. All measurements were 
arranged by blinded medical/technical personnel. 
 The SBP (mm Hg) was tested automatically (Hellige ECB 
561). 
 Peak expiratory fl ow (l/min) and forced expiratory volume in 
the fi rst second (FEV 1 , liter) were measured with an electronic 
pocket spirometer (Vitalograph 2120). The instrument incorporat-
ed diary facilities, with a microcomputer display for questions pre-
programmed by the staff. 
 Heart rate variability was measured with the Pro Sci Card com-
puter program. A trend quotient was formed from the relationship 
of the average of the fi rst 40 to the average of the last 40 measured 
R-R intervals and had a normal range of between 0.94 and 1.06. 
Only those measurements for which the number of the artifacts and 
extra systoles was under 3% were valid. The heart frequency at rest 
in beats per minute, the CV in percent, and the RMSSD were cal-
culated as: 
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 where (R – R  ) i  is the length of the i th  R-R interval in ms, n is the 
number of the R-R intervals at rest in ms and the frequency bands 
of spectral analysis with the ranges low frequency (LF: 0.01–
0.05 Hz), middle frequency (MF: 0.05–0.15 Hz), high frequency 
(HF: 0.15–0.50 Hz). The heart frequency was entered as a mean 
value of the measurement over a 5-min rest period. The coeffi cient 
of variation under conditions of rest (CV) was calculated from 150 
R-R intervals. The spectral analysis of the sequence of the R-R in-
tervals over a 5-min period took place using the fast Fourier trans-
formation procedure with 8 series of data, each with 256 and 128 
overlapping points (total 1,152). 
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 The study was also performed using the State-Trait Anger Ex-
pression Inventory (STAXI), and Health Survey (SF-36).  
 The STAXI is a procedure for measuring anger and the expres-
sion of anger (Cronbach’s Alpha for women = 0.75; retest correla-
tion for women 8 weeks later = 0.70–0.76) consisting of 44 items, 
which form fi ve scales: 
 – State-Anger (SA) – subjective state of anger at time of measure-
ment 
 – Trait-Anger (TA) – readiness to react with anger (normal value 
= 18.1, SD = 5.34) 
 – Anger-In (AI) – tendency to repress anger (normal value = 16.0, 
SD = 4.04) 
 – Anger-Out (AO) – tendency to direct anger outwards (normal 
value = 13.0, SD = 4.02) 
 – Anger-Control – tendency to keep anger under control (normal 
value = 22.4, SD = 5.29). 
 The values of SA and TA range from 10 to 40 and the others 
from 8 to 32  [32] . 
 The SF-36 was designed by Steward and Ware in 1992 to obtain 
individual reports from patients regarding their health-related 
quality of life, independently of their current state of health and 
age. It consists of a questionnaire with 36 items categorized accord-
ing to several subject areas. The items record eight dimensions of 
subjective health: physical functioning, role limitations due to 
physical health (role-physical), bodily pain, general health percep-
tions, vitality, social functioning, role limitations due to emotional 
problems (role emotional) and mental health. The items and scales 
of the SF-36 were calculated so that a higher score corresponds to 
a better state of health. A higher score in functionality, for instance, 
indicates better functionality in the subject and a higher score on 
the pain scale means freedom from pain. The raw values from the 
scales are converted into transformed scale values (T values). Reli-
ability testing shows internal consistency between approximately 
0.77 and 0.93  [33] . 
 Design 
 All women participated in PMR or sham training (see below) 
and were tested in the morning (8:  00 or 9:  00 a.m.) under controlled 
room temperature and light conditions. Participants were instruct-
ed not to eat or drink (only water was allowed), and to abstain from 
sport, alcohol and caffeine during the 24-hour period preceding the 
experiment [cf. also  34] . 
 We treated the members of the PMR-G in 30-min PMR sessions 
three times a week over a period of 8 weeks in 2004 and 2005. The 
PMR procedure consisted of two steps. First, the subjects deliber-
ately applied tension to certain muscle groups and then released the 
tension and focused on how the muscles relaxed during the process. 
The sequence was as follows: right foot, right lower leg and foot, 
entire right leg, left foot, left lower leg and foot, entire left leg, right 
hand, right forearm and hand, entire right arm, left hand, left fore-
arm and hand, entire left arm, abdomen, chest, neck and shoulders, 
face. Two subjects were left-handed and began with their left feet. 
We took care to ensure that the relaxation exercises were the only 
content of the group session. The subjects received precise instruc-
tions for daily practice at home: they were to spend about 15 min 
twice a day maintaining their profi ciency by practicing a shortened 
form of the procedure: lower limbs, abdomen and chest, arms, 
shoulders and neck, and fi nally face.  
 The CG was prescribed movement with their extremities as a 
placebo intervention, also in 30-min sessions three times a week. 
This group received instructions for daily practice at home as well, 
using a shortened series of exercises.  
 Six women failed to appear more than twice for the evaluations 
and dropped out of the study ( fi g. 1 ).  
 Fig. 1. Flow diagram of patients’ progress 
through the phases of the trial. 
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 Both groups were tested weekly. The questionnaires were fi lled 
out by the patients both independently and anonymously. The 
blinded professional staff checked the data for completeness. The 
data were twice fed independently to the computer and automati-
cally checked for deviations. Of the entries, 1.9% were identifi ed 
accordingly as erroneous and adjusted. The study was concluded 
according to plan. 
 Statistical Analysis 
 We used the statistical program SPSS, v11 (SPSS Inc., Chicago, 
Ill., USA). Since the data were not normally distributed, the Mann-
Whitney U test was performed for comparison of continuous 
 variables. We employed difference in change between both groups 
with its 95% confi dence intervals, and probability for reporting the 
treatment results  [31] according to the intend-to-treat prin ciple. 
 Source of Funding and Ethical Considerations 
 The study was planned and conducted in accordance with the 
Declaration of Helsinki and ethical laws pertaining to the medical 
professions. Its design was approved by the clinic’s Committee on 
Human Subjects. The study was conducted independently of any 
institutional infl uence and was not funded. 
 Results 
 The women’s basic data at the time of randomization 
are presented in  table 1 .  
 Table 2 shows initial and fi nal measurements of the 
blood pressure, lung and heart parameters, as well as the 
statistical analysis of the difference in the changes be-
tween the PMR-G and the CG. 
 Among this study population, the SBP was signifi cant-
ly reduced after PMR ( table 2 ). The forced expiratory 
volume in the fi rst second and peak expiratory fl ow rose 
signifi cantly ( table 2 ). Heart rate fell after relaxation ( ta-
ble 2 ). The CV and RMSSD values as well as the HF range 
in the spectral analysis were higher than before relaxation 
in the sense of increased parasympathetic activity ( ta-
ble 2 ). Average LF and MF values decreased after relax-
ation ( table 2 ), which is consistent with a possible reduc-
tion in sympathetic activity.  
Age 
years
Pregnancy
weeks
Live in a 
partnership
Profession
worker employee homemaker
PMR-G (n = 32) 25.583.5 17.585.5 28 (87.5%) 13 (40.6%) 9 (28.1%) 10 (31.2%)
CG (n = 32) 26.983.0 18.584.5 29 (90.6%) 12 (37.5%) 8 (25.5%) 12 (37.5%)
Values for age and pregnancy are expressed as mean 8 standard deviation. 
Table 2. Initial and fi nal measurement of physiological parameters
SBP
mmHg
FEV1
l
PEF
l/min
HR
bpm
CV
%
RMSSD
ms
LF
Hz
MF
Hz
HF
Hz
Initial
PMR-G (n = 32) 136.389.0 1.6980.6 333.6816.3 76.785.0 4.382.5 22.388.9 1.880.7 2.281.0 1.280.6
CG (n = 32) 133.989.1 1.7580.5 337.8816.9 75.084.7 4.882.2 21.687.3 1.880.6 2.180.8 1.380.4
Final
PMR-G (n = 32) 120.386.9 2.2280.5 395.7810.9 66.583.7 6.682.6 27.185.9 1.380.2 1.580.5 1.780.3
CG (n = 32) 132.289.1 1.7580.5 345.1812.7 73.484.9 5.282.8 22.887.4 1.680.9 2.080.7 1.480.6
DI
95% CI
–14.3
–18.5, –10.1
0.5
0.2, 0.8
54.8
47.7, 61.9
 –8.6
–10.9, –6.3
1.9
0.7, 3.1
3.6
0.7, 3.1
–0.3
–0.6, 0.1
–0.6
–1.0, –0.2
0.4
0.2, 0.6
p (U test)  <0.001 0.005 <0.001  <0.001 0.01 0.04  0.07  0.01 0.01
Values are expressed as  mean 8 standard deviation, except where otherwise indicated. 
DI = Difference in change between the two groups; FEV1 = forced expiratory volume in the fi rst second; PEF = peak expiratory fl ow; 
HR = heart frequency; CV = coeffi cient of variation; HF = high frequency; LM = low frequency; MF = middle frequency.
Table 1. Basic data
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 At the beginning of the study, both groups had rela-
tively increased STAXI scores and decreased SF-36 T 
values ( tables 3 and  4 ).  Tables 3 and  4 summarize PMR-
G versus CG differences in change on the STAXI and 
SF-36 scales over the course of the study.  
 Figure 2 shows, as an example, the change over time 
on the STAXI AO scale. PMR was associated with an 
initially (1st to approximately 5th or 6th week of treat-
ment) gradual, but later (from approximately the 5th or 
6th week) relatively rapid change in most of the tested 
categories. 
State-Anger Trait-
Anger
Anger-In Anger-Out Anger-
Control
Initial
PMR-G (n = 32) 24.981.9 25.781.8 19.583.2 16.883.1 22.184.5 
CG (n = 32) 24.382.6 25.382.3 19.583.4 16.184.9 21.684.8
Final
PMR-G (n = 32) 19.683.3 18.683.9 18.283.4 13.685.0 22.384.0 
CG (n = 32) 23.583.8 24.283.5 19.383.6 15.685.4 21.885.1
DI
95% CI
–4.5 
–5.9, –3.1
–6.0
–7.3, –4.7
–1.1
–2.5, 0.3
–2.7
–4.8, –0.6
=1.0
–1.3, 3.3
p (U test) <0.01 <0.01  0.06 <0.01  0.39
Values are expressed as  mean 8 SD, except where otherwise indicated. 
Table 3. Changes in STAXI scores
Table 4. Changes on SF-36 health survey scales (T values)
Physical 
functioning 
Role 
physical 
Bodily pain General 
health 
perceptions 
Vitality Social 
functioning
Role
emotional 
Mental
health 
Initial 
PMR-G (n = 32) 85.286.6 88.387.9 84.289.5 73.489.8 60.189.5 68.289.8 72.188.5 65.188.7
CG (n = 32) 87.187.9 86.186.9 86.388.9 74.889.9 61.089.0 69.789.9 70.489.3 64.889.5 
Final
PMR-G (n = 32) 90.185.1 95.285.8 90.289.0 78.889.8 70.287.1 83.988.1 83.787.6 72.487.8
CG (n = 32) 88.686.0 88.286.9 87.189.6 74.588.7 62.589.2 71.189.4 71.589.1 66.389.5
DI,
95% CI
3.4
–0.2, 6.6
4.8
 1.4, 8.2
5.2
 0.7, 9.7
5.7
 1.0, 10.4
8.6
 4.3, 12.9
14.3
 9.7, 18.9
10.5
 6.3, 14.7
5.8
 1.4, 10.2
p  0.06  0.02  0.04  0.02 <0.001 <0.001 <0.001  0.01
 Values are expressed as mean 8 standard deviation, except where otherwise indicated. 
 Fig. 2. State-Trait Anger Expression Inventory: Anger-Out. 
 Nickel  et al.
 
 Psychother Psychosom 2006;75:237–243 242
 Discussion 
 Analysis of the basic data permitted a comparison of 
the two groups.  
 PMR was signifi cantly more effective than placebo in-
tervention on all tested parameters. This supports the re-
sults of earlier trials which indicated that subjects with 
bronchial asthma could benefi t from relaxation tech-
niques  [18–20] . 
 Our study confi rmed earlier study fi ndings showing an 
enhancing effect of relaxation training on lung parame-
ters  [18, 19] . Lung function after PMR was signifi cantly 
improved, although airway hyperactivity in asthma pa-
tients can cause resistance in the pathways in response to 
therapy [cf.  24] . 
 A signifi cant decline in heart rate was apparent in the 
PMR-G following 10-min relaxation. The data for asth-
ma patients showed an increase in RMSSD, CV and HF 
values. This speaks for enhanced parasympathetic con-
trol, e.g. as an effect of relaxation. Average LF and MF 
values decrease signifi cantly after relaxation, which is 
consistent with a possible reduction in sympathetic activ-
ity [cf.  35] . Lehrer et al.  [36] found that heart rate vari-
ability biofeedback has strong infl uences on pulmonary 
function. Since the parasympathetic nervous system con-
tributes to the control of respiration through the auto-
matic nervous system, asthma patients can indirectly in-
fl uence relaxation through PMR. Perception training 
with added resistive loads may help patients to detect an 
increase in air fl ow obstruction due to asthma before it 
becomes severe [cf.  2] . Through relaxation exercises, in 
addition to other forms of stress management, the self-
perception of one’s own body and the conscious sensation 
of respiration are strengthened  [36–38 , cf. also  39] . The 
positive infl uence of stress management has also been 
demonstrated in various stressful situations or with other 
mentally infl uenced diseases  [40] . The possibility we have 
indicated needs to be validated in a long-term observa-
tion study.  
 On initial testing, each subject had raised STAXI val-
ues simultaneously, indicating the increase resulting from 
the women’s specifi c situation. Women with high SA 
scores experience relatively intense feelings of anger and 
those with high TA scores experience anger relatively fre-
quently  [32] . Whether they suppress their anger or direct 
it inwards can be assessed through the AI, and AO scales. 
AI and AO are independent of each other. The patients 
can have high scores on both scales  [32] . Persons with 
high Anger-Control scores expend a lot of energy control-
ling their emotions. In our trial, comparison of the end 
points showed a signifi cantly greater rate of change in the 
PMR than in the CG on the STAXI SA, TA, and AO 
scales.  
 At the beginning of the study, both groups had rela-
tively low SF-36 scores. As these scores are dependent on 
the state of mind, this indicated a subjective reduction in 
health-related quality of life. After treatment, the role 
physical, bodily pain, general health perceptions, vitality, 
social activities and emotional problems that had inter-
fered with work or other daily activities and even mental 
health improved signifi cantly  [33] . 
 The clearly defi ned time frame and the relatively small 
amount of time needed to be invested in the therapy with 
PMR proved to facilitate compliance. The women showed 
a signifi cant reduction in aggression potential following 
treatment. In addition, they learnt a relaxation technique 
which they could apply later, whenever needed. In com-
parison with other therapeutic measures in the treatment 
of somatic complaints, relaxation techniques have not 
proven to be superior in a number of studies  [41, 42] . The 
results obtained from them have been inconclusive  [43–
45] .  There are, however, hints that such techniques are 
benefi cial in several diseases  [17] . 
 Our fi ndings provide evidence that pregnant women 
with bronchial asthma may benefi t from functional relax-
ation. Results from this study and from previous studies 
provide supportive evidence for the usefulness of relax-
ation in bronchial asthma. PMR may be an effective, in-
expensive intervention to improve bronchial asthma and 
its accompanying adverse physiological effects. However, 
this study had several methodological limitations. First, 
the sample size was relatively small. Second, the survey 
consisted only of relatively healthy subjects. Third, the 
effects in this study are acute, measured after an active 
intervention. There is no evidence yet that PMR will have 
similar effects during an asthma exacerbation. Fourth, 
the length of this trial was only 2 months. That possibly 
reduced the dropout rate. Fifth, it could not be guaran-
teed that the women in fact obeyed our instructions, 
which was necessary for stable baseline conditions for 
psychophysiological measures. This could limit the valid-
ity of our measurements. The relatively slight changes in 
the CG may have been associated with this constraint. 
 Additional research is needed to see if these results can 
be replicated and how long-lasting the benefi ts are. 
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